Initiating a large, global CNS trial is no small task. But when it is a trial that involves 100 sites and thousands of required documents? You need to call in the experts.
For this pivotal Phase 3 migraine study, Clinilabs was engaged to execute rapid study startup across a diverse geographic footprint. The challenge: navigate site contracting, qualification, regulatory document collection, and IRB submissions in record time.
Download the case study to discover how Clinilabs cut typical CNS trial startup timelines by over 6 months through:
- Centralized digital workflows using validated eClinical platforms
- Automated document management and eSignature
- Seamless execution of 200+ confidential disclosure agreements, 100 site packages, and IRB applications
- Experienced startup teams and rigorous milestone tracking
